<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36011394</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>An Atypical Presentation of Upper Motor Neuron Predominant Juvenile Amyotrophic Lateral Sclerosis Associated with <i>TARDBP</i> Gene: A Case Report and Review of the Literature.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1483</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes13081483</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that can rarely affect young individuals. Juvenile ALS (JALS) is defined for individuals with an onset of the disease before the age of 25. The contribution of genetics to ALS pathology is a field of growing interest. One of the differences between adult-onset ALS and JALS is their genetic background, with a higher contribution of genetic causes in JALS. We report a patient with JALS and a pathogenic variant in the TARDBP gene (c.1035C &gt; G; p.Asn345Lys), previously reported only in adult-onset ALS, and with an atypical phenotype of marked upper motor neuron predominance. In addition, the proband presented an additional variant in the NEK1 gene, c.2961C &gt; G (p.Phe987Leu), which is classified as a variant of unknown significance. Segregation studies showed a paternal origin of the TARDBP variant, while the variant in NEK1 was inherited from the mother. We hypothesize that the NEK1 variant acts as a disease modifier and suggests the possibility of a functional interaction between both genes in our case. This hypothesis could explain the peculiarities of the phenotype, penetrance, and the age of onset. This report highlights the heterogeneity of the phenotypic presentation of ALS associated with diverse pathogenic genetic variants.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>S&#xe1;nchez-Tejerina</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5624-638X</Identifier><AffiliationInfo><Affiliation>Neuromuscular Diseases Unit, European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Department of Neurology, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 119, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Restrepo-Vera</LastName><ForeName>Juan Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Unit, European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Department of Neurology, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 119, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovira-Moreno</LastName><ForeName>Eulalia</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5483-7031</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Universitat Aut&#xf2;noma de Barcelona, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Codina-Sola</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Universitat Aut&#xf2;noma de Barcelona, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llaurad&#xf3;</LastName><ForeName>Arnau</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Unit, European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Department of Neurology, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 119, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotoca</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3400-1434</Identifier><AffiliationInfo><Affiliation>Neuromuscular Diseases Unit, European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Department of Neurology, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 119, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvado</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Unit, European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Department of Neurology, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 119, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raguer</LastName><ForeName>N&#xfa;ria</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9471-9096</Identifier><AffiliationInfo><Affiliation>Department of Clinical Neurophysiology, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 119, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Arum&#xed;</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Universitat Aut&#xf2;noma de Barcelona, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juntas-Morales</LastName><ForeName>Ra&#xfa;l</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neuromuscular Diseases Unit, European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Department of Neurology, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 119, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019683" MajorTopicYN="N">Penetrance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TARDBP</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">juvenile amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">upper motor neuron predominant disorder</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36011394</ArticleId><ArticleId IdType="pmc">PMC9407925</ArticleId><ArticleId IdType="doi">10.3390/genes13081483</ArticleId><ArticleId IdType="pii">genes13081483</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic Lateral Sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S., Goizet C., Soulages A., Vallat J.-M., Masson G.L. Genetics of Amyotrophic Lateral Sclerosis: A Review. J. Neurol. Sci. 2019;399:217&#x2013;226. doi: 10.1016/j.jns.2019.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.02.030</ArticleId><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Orban P., Devon R.S., Hayden M.R., Leavitt B.R. Handbook of Clinical Neurology. Volume 82. Elsevier; Amsterdam, The Netherlands: 2007. Chapter 15 Juvenile amyotrophic lateral sclerosis; pp. 301&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">18808900</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Brown R.H. Neuromuscular Disorders of Infancy, Childhood, and Adolescence. Elsevier; Amsterdam, The Netherlands: 2015. Juvenile Amyotrophic Lateral Sclerosis; pp. 146&#x2013;159.</Citation></Reference><Reference><Citation>Kacem I., Sghaier I., Bougatef S., Nasri A., Gargouri A., Ajroud-Driss S., Gouider R. Epidemiological and Clinical Features of Amyotrophic Lateral Sclerosis in a Tunisian Cohort. Amyotroph. Lateral Scler. Front. Degener. 2020;21:131&#x2013;139. doi: 10.1080/21678421.2019.1704012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1704012</ArticleId><ArticleId IdType="pubmed">31858811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehky T., Grunseich C. Juvenile Amyotrophic Lateral Sclerosis: A Review. Genes. 2021;12:1935. doi: 10.3390/genes12121935.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12121935</ArticleId><ArticleId IdType="pmc">PMC8701111</ArticleId><ArticleId IdType="pubmed">34946884</ArticleId></ArticleIdList></Reference><Reference><Citation>Esselin F., Mouzat K., Polge A., Juntas-Morales R., Pageot N., De la Cruz E., Bernard E., Lagrange E., Danel V., Alphandery S., et al. Clinical Phenotype and Inheritance in Patients with C9ORF72 Hexanucleotide Repeat Expansion: Results from a Large French Cohort. Front. Neurosci. 2020;14:316. doi: 10.3389/fnins.2020.00316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00316</ArticleId><ArticleId IdType="pmc">PMC7199526</ArticleId><ArticleId IdType="pubmed">32410933</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara K., Ishihara T., Onodera O., Ishiguro H. A New Japanese Amyotrophic Lateral Sclerosis Family with TARDBP (TDP-43) Mutation. Neurol. Clin. Neurosci. 2019;7:101&#x2013;102. doi: 10.1111/ncn3.12250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ncn3.12250</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T., Iijima M., Shimizu Y., Yoshizawa H., Miyashiro M., Onizuka H., Yamamoto T., Nishiyama A., Suzuki N., Aoki M., et al. P.N345K Mutation in TARDBP in a Patient with Familial Amyotrophic Lateral Sclerosis: An Autopsy Case. Neuropathology. 2019;39:286&#x2013;293. doi: 10.1111/neup.12559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12559</ArticleId><ArticleId IdType="pubmed">31124595</ArticleId></ArticleIdList></Reference><Reference><Citation>Leventoux N., Morimoto S., Hara K., Nakamura S., Ozawa F., Mitsuzawa S., Akiyama T., Nishiyama A., Suzuki N., Warita H., et al. Generation of an ALS Human IPSC Line KEIOi001-A from Peripheral Blood of a Charcot Disease-Affected Patient Carrying TARDBP p.N345K Heterozygous SNP Mutation. Stem Cell Res. 2020;47:101896. doi: 10.1016/j.scr.2020.101896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2020.101896</ArticleId><ArticleId IdType="pubmed">32659732</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 Is a Component of Ubiquitin-Positive Tau-Negative Inclusions in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>De Boer E.M.J., Orie V.K., Williams T., Baker M.R., De Oliveira H.M., Polvikoski T., Silsby M., Menon P., van den Bos M., Halliday G.M., et al. TDP-43 Proteinopathies: A New Wave of Neurodegenerative Diseases. J. Neurol. Neurosurg. Psychiatry. 2021;92:86&#x2013;95. doi: 10.1136/jnnp-2020-322983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322983</ArticleId><ArticleId IdType="pmc">PMC7803890</ArticleId><ArticleId IdType="pubmed">33177049</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois-Moutal L., Perez-Miller S., Scott D.D., Miranda V.G., Mollasalehi N., Khanna M. Structural Insights Into TDP-43 and Effects of Post-Translational Modifications. Front. Mol. Neurosci. 2019;12:301. doi: 10.3389/fnmol.2019.00301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00301</ArticleId><ArticleId IdType="pmc">PMC6934062</ArticleId><ArticleId IdType="pubmed">31920533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho M.A., Baloh R.H., Chakraverty S., Mayo K., Norton J.B., Levitch D., Hatanpaa K.J., White C.L., Bigio E.H., Caselli R., et al. TDP-43 A315T Mutation in Familial Motor Neuron Disease. Ann. Neurol. 2008;63:535&#x2013;538. doi: 10.1002/ana.21344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21344</ArticleId><ArticleId IdType="pmc">PMC2747362</ArticleId><ArticleId IdType="pubmed">18288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Velde C.V., Bouchard J.-P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP Mutations in Individuals with Sporadic and Familial Amyotrophic Lateral Sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., Snead D., Lee J.J., McCaffery J.M., Shorter J., Gitler A.D. TDP-43 Is Intrinsically Aggregation-Prone, and Amyotrophic Lateral Sclerosis-Linked Mutations Accelerate Aggregation and Increase Toxicity. J. Biol. Chem. 2009;284:20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M., Romano V., Avenda&#xf1;o-V&#xe1;zquez S.E., Bembich S., Buratti E., Baralle F.E. Role of Selected Mutations in the Q/N Rich Region of TDP-43 in EGFP-12xQ/N-Induced Aggregate Formation. Brain Res. 2012;1462:139&#x2013;150. doi: 10.1016/j.brainres.2012.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.031</ArticleId><ArticleId IdType="pubmed">22406069</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Valdmanis P., Millecamps S., Lionnet C., Blasco H., Mouzat K., Daoud H., Belzil V., Morales R., Pageot N., et al. Phenotype and Genotype Analysis in Amyotrophic Lateral Sclerosis with TARDBP Gene Mutations. Neurology. 2012;78:1519&#x2013;1526. doi: 10.1212/WNL.0b013e3182553c88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182553c88</ArticleId><ArticleId IdType="pubmed">22539580</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng F., Wang H., Liu J., Wang Z., Xu B., Zhao K., Tao X., He Z., Yang F., Huang X. Genetic and Clinical Features of Chinese Sporadic Amyotrophic Lateral Sclerosis Patients with TARDBP Mutations. Brain Behav. 2021;11:e2312. doi: 10.1002/brb3.2312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2312</ArticleId><ArticleId IdType="pmc">PMC8413724</ArticleId><ArticleId IdType="pubmed">34333853</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L., Ratti A., Gellera C., Buratti E., Castellotti B., Carlomagno Y., Ticozzi N., Mazzini L., Testa L., Taroni F., et al. High Frequency of TARDBP Gene Mutations in Italian Patients with Amyotrophic Lateral Sclerosis. Hum. Mutat. 2009;30:688&#x2013;694. doi: 10.1002/humu.20950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20950</ArticleId><ArticleId IdType="pubmed">19224587</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.-J., Lin H.-X., Liu G.-L., Tao Q.-Q., Ni W., Xiao B.-G., Wu Z.-Y. The Investigation of Genetic and Clinical Features in Chinese Patients with Juvenile Amyotrophic Lateral Sclerosis. Clin. Genet. 2017;92:267&#x2013;273. doi: 10.1111/cge.13015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13015</ArticleId><ArticleId IdType="pubmed">28429524</ArticleId></ArticleIdList></Reference><Reference><Citation>Newell K., Paron F., Mompean M., Murrell J., Salis E., Stuani C., Pattee G., Romano M., Laurents D., Ghetti B., et al. Dysregulation of TDP-43 Intracellular Localization and Early Onset ALS Are Associated with a TARDBP S375G Variant. Brain Pathol. 2019;29:397&#x2013;413. doi: 10.1111/bpa.12680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12680</ArticleId><ArticleId IdType="pmc">PMC6875182</ArticleId><ArticleId IdType="pubmed">30461104</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Fu S., Lei J., Wu H., Shi S., Chen K., Hu J., Xu X. Identification of Novel FUS and TARDBP Gene Mutations in Chinese Amyotrophic Lateral Sclerosis Patients with HRM Analysis. Aging. 2020;12:22859. doi: 10.18632/aging.103967.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103967</ArticleId><ArticleId IdType="pmc">PMC7746354</ArticleId><ArticleId IdType="pubmed">33159016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.-Y., Peng Y., Wang X.-N., Liu M.-S., Li X.-G., Cui L.-Y. Screening of the TARDBP Gene in Familial and Sporadic Amyotrophic Lateral Sclerosis Patients of Chinese Origin. Neurobiol. Aging. 2012;33:2229.e11&#x2013;2229.e18. doi: 10.1016/j.neurobiolaging.2012.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.03.014</ArticleId><ArticleId IdType="pubmed">22575358</ArticleId></ArticleIdList></Reference><Reference><Citation>Black H.A., Leighton D.J., Cleary E.M., Rose E., Stephenson L., Colville S., Ross D., Warner J., Porteous M., Gorrie G.H., et al. Genetic Epidemiology of Motor Neuron Disease-Associated Variants in the Scottish Population. Neurobiol. Aging. 2017;51:178.e11&#x2013;178.e20. doi: 10.1016/j.neurobiolaging.2016.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.12.013</ArticleId><ArticleId IdType="pmc">PMC5302213</ArticleId><ArticleId IdType="pubmed">28089114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J., Goodall E.F., Smith W., Highley J.R., Masanzu R., Hartley J.A., Hibberd R., Hollinger H.C., Wharton S.B., Morrison K.E., et al. Broad Clinical Phenotypes Associated with TAR-DNA Binding Protein (TARDBP) Mutations in Amyotrophic Lateral Sclerosis. Neurogenetics. 2010;11:217&#x2013;225. doi: 10.1007/s10048-009-0218-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-009-0218-9</ArticleId><ArticleId IdType="pubmed">19760257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J., Allred P., Bali T., Pestronk A., Goate A., Miller T.M., Mitra R.D., Ravits J., Harms M.B., Baloh R.H. Amyotrophic Lateral Sclerosis Onset Is Influenced by the Burden of Rare Variants in Known Amyotrophic Lateral Sclerosis Genes: Rare Variants in ALS Genes. Ann. Neurol. 2015;77:100&#x2013;113. doi: 10.1002/ana.24306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24306</ArticleId><ArticleId IdType="pmc">PMC4293318</ArticleId><ArticleId IdType="pubmed">25382069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Xie Y., Zheng M., Lin J., Huang P., Pei Z., Yao X. Clinical and Genetic Features of Patients with Amyotrophic Lateral Sclerosis in Southern China. Eur. J. Neurol. 2020;27:1017&#x2013;1022. doi: 10.1111/ene.14213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14213</ArticleId><ArticleId IdType="pubmed">32166880</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zhou R.-L., Zhang W., Che C.-H., Feng S.-Y., Huang H.-P., Liu C.-Y., Zou Z.-Y. Novel TARDBP Missense Mutation Caused Familial Amyotrophic Lateral Sclerosis with Frontotemporal Dementia and Parkinsonism. Neurobiol. Aging. 2021;107:168&#x2013;173. doi: 10.1016/j.neurobiolaging.2021.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.05.017</ArticleId><ArticleId IdType="pubmed">34175147</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J.A., Min J., Staropoli J.F., Collin E., Bi S., Feng X., Barone R., Cao Y., O&#x2019;Malley L., Xin W., et al. SOD1, ANG, TARDBP and FUS Mutations in Amyotrophic Lateral Sclerosis: A United States Clinical Testing Lab Experience. Amyotroph. Lateral Scler. 2012;13:217&#x2013;222. doi: 10.3109/17482968.2011.643899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.643899</ArticleId><ArticleId IdType="pubmed">22292843</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroppo P., Camuzat A., Guillot-Noel L., Thomas-Ant&#xe9;rion C., Couratier P., Wong T.H., Teichmann M., Golfier V., Auriacombe S., Belliard S., et al. Defining the Spectrum of Frontotemporal Dementias Associated with TARDBP Mutations. Neurol. Genet. 2016;2:e80. doi: 10.1212/NXG.0000000000000080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000080</ArticleId><ArticleId IdType="pmc">PMC4882769</ArticleId><ArticleId IdType="pubmed">27280171</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghero G., Pugliatti M., Marrosu F., Marrosu M.G., Murru M.R., Floris G., Cannas A., Parish L.D., Occhineri P., Cau T.B., et al. Genetic Architecture of ALS in Sardinia. Neurobiol. Aging. 2014;35:2882.e7&#x2013;2882.e12. doi: 10.1016/j.neurobiolaging.2014.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.012</ArticleId><ArticleId IdType="pmc">PMC4252367</ArticleId><ArticleId IdType="pubmed">25123918</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.-F., Wang Q., Krueger B.J., et al. Exome Sequencing in Amyotrophic Lateral Sclerosis Identifies Risk Genes and Pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., M&#xfc;ller K., Wieland T., Weydt P., B&#xf6;hm S., Lul&#xe9; D., H&#xfc;bers A., Neuwirth C., Weber M., Borck G., et al. NEK1 Mutations in Familial Amyotrophic Lateral Sclerosis. Brain. 2016;139:e28. doi: 10.1093/brain/aww033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww033</ArticleId><ArticleId IdType="pubmed">26945885</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., van Doormaal P.T.C., Dekker A.M., Ticozzi N., Kenna B.J., Diekstra F.P., van Rheenen W., van Eijk K.R., Jones A.R., Keagle P., et al. NEK1 Variants Confer Susceptibility to Amyotrophic Lateral Sclerosis. Nat. Genet. 2016;48:1037&#x2013;1042. doi: 10.1038/ng.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., Van Mossevelde S., Dillen L., De Bleecker J.L., Moisse M., Van Damme P., Van Broeckhoven C., van der Zee J., Engelborghs S., Crols R., et al. NEK1 Genetic Variability in a Belgian Cohort of ALS and ALS-FTD Patients. Neurobiol. Aging. 2018;61:255.e1&#x2013;255.e7. doi: 10.1016/j.neurobiolaging.2017.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.08.021</ArticleId><ArticleId IdType="pubmed">28935222</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H., Ishiura H., Mitsui J., Takahashi Y., Matsukawa T., Yoshimura J., Doi K., Morishita S., Goto J., Toda T., et al. Loss-of-Function Variants in NEK1 Are Associated with an Increased Risk of Sporadic ALS in the Japanese Population. J. Hum. Genet. 2021;66:237&#x2013;241. doi: 10.1038/s10038-020-00830-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s10038-020-00830-9</ArticleId><ArticleId IdType="pubmed">32920598</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Doronzio P.N., Conte A., Marangi G., Martello F., Bisogni G., Meleo E., Colavito D., Del Giudice E., Patanella A.K., et al. Novel Variants and Cellular Studies on Patients&#x2019; Primary Fibroblasts Support a Role for NEK1 Missense Variants in ALS Pathogenesis. Hum. Mol. Genet. 2021;30:65&#x2013;71. doi: 10.1093/hmg/ddab015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab015</ArticleId><ArticleId IdType="pubmed">33445179</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L., He X., Cui B., Zhao F., Zhou C. NEK1 Mutations and the Risk of Amyotrophic Lateral Sclerosis (ALS): A Meta-Analysis. Neurol. Sci. 2021;42:1277&#x2013;1285. doi: 10.1007/s10072-020-05037-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-05037-6</ArticleId><ArticleId IdType="pubmed">33462636</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>